Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

NCT02831543 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

354

Enrollment

INDUSTRY

Sponsor class

Conditions

Functional Dyspepsia

Interventions

DRUG: Motireb 5/100 mg
DRUG: Mosapride citrate
DRUG: Placebo

Sponsor

IlDong Pharmaceutical Co Ltd